| Old Articles: <Older 6341-6350 Newer> |
 |
InternetNews January 23, 2007 Roy Mark |
Court Rejects Orphan Works Appeal Ninth Circuit rules 'no compelling reason' for First Amendment review of copyright law.  |
InternetNews January 22, 2007 Roy Mark |
Hurd: Options Exercise Was Legal HP chief denies any wrongdoing in letter to House committee probing the $1.37 million deal.  |
PC Magazine January 10, 2007 Aaron Dalton |
Washington's Net Change How the Democrat-controlled Congress could affect technology legislation.  |
PC Magazine January 10, 2007 Seth Porges |
RFID Tags: Everywhere at Once RFID tags are showing up in everything from running shoes to passports. But are they making you safer or turning you into a target?  |
Geotimes January 2007 Erin Gleeson |
Without a Budget, NSF Loses The new Congress does not intend to pass a 2007 National Science Foundation budget, and instead plans to run the federal government on a continuing resolution for all of fiscal year 2007.  |
AFP eWire January 22, 2007 |
Eight in 10 Give to Charity, but Average Giving Down 83% of Americans gave to charity in 2006, but the average annual contribution among those making gifts fell from $1,352 in 2005 to $1,220, according to a new poll.  |
AFP eWire January 22, 2007 |
Comments on USPS Mailing Standards Due at End of January According to the Alliance for Nonprofit Mailers, the pricing proposal reflects changes in operations. The USPS intends to ensure that all types of mail cover its costs.  |
HBS Working Knowledge January 22, 2007 Michael Roberts |
The Immigrant Technologist: Studying Technology Transfer with China Professor William Kerr discusses the phenomena of technology transfer and implications for U.S.-based businesses and policymakers.  |
The Motley Fool January 22, 2007 Jack Uldrich |
Solar Power Goes to Washington Solar power's success in lobbying Congress could benefit investors.  |
The Motley Fool January 22, 2007 Michael P. Cecil |
Will Medicare Negotiate With Drug Companies? One of the bedrock principles of our economic system is that those buying more of a product receive a discount. Wouldn't empowering Medicare to save taxpayers' money be widely embraced as a great idea? But how would pharma investors see it?  |
| <Older 6341-6350 Newer> Return to current articles. |